Gap Analysis of Economic Incentives for Antimicrobials in APEC Economies

  14 March 2024

Addressing barriers to market entry and new drug development

This gap analysis identifies challenges in addressing antimicrobial resistance (AMR) and incentivizing the development of novel antimicrobials. A survey distributed among APEC economies revealed insufficient targeted reimbursement processes and pull-incentives. To address these issues, strengthening financing mechanisms for sustainable antimicrobial R&D, supporting public-private partnerships, evaluating pull incentive pilot approaches, and exploring international collaborative mechanisms is crucial. Integrating AMR into international development cooperation initiatives can enhance global access to essential health products.

Author(s): APEC Health Working Group
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed